• HOME
  • RESEARCH
  • PEOPLE
    • Matthew S. Davids
    • Current Lab Members >
      • Christine Ryan, MD
      • Stephen Chong, PhD
      • Fen Zhu, PhD
      • Johannes Hildebrand, MSc
      • Mary Collins, BS
      • Liam Hackett, AB
    • Alumni >
      • Charles Herbaux, MD
      • Rebecca Valentin, MD
      • Timothy Lehmberg, B.A.
      • Stephanie Grabow, PhD
      • Simon Husby, MD
  • PUBLICATIONS
  • JOBS
  • SUPPORT US
  • NEWS
    • Awards and Recognition
  • CONTACT
Davids Lab - Translational CLL Research

The Davids Lab
TRANSLATIONAL CLL RESEARCH

Picture

Johannes Hildebrand, M.Sc.

PhD candidate 
 
M.Sc., 2018, Ludwig-Maximilians-University (LMU) München, Munich
 
Johannes joined the Davids Lab in 2022 for a 3-month research rotation towards the end of his PhD in Professor Oliver Weigert´s lab at the LMU hospital. His thesis focuses on aberrant cathepsin S signaling in follicular lymphoma.

With increasing evidence of cathepsins being capable of cleaving BH3 family members, he started investigating therapeutic vulnerabilities of lymphomas and other cancers with cathepsin S alterations. He hopes to improve therapy for a subset of cancers and to increase awareness for the underestimated yet complex protease network.
 
He brings to the Davids Lab his previous experience in translational lymphoma research, including molecular biology methods like protein assays, flow cytometry, and co-culture systems.
 
In his spare time, he likes to explore the nature, do mountain and ocean sports, or meet and cook with friends.

JAHildebrand@MGH.Harvard.edu
 


 HOME | RESEARCH | PEOPLE | PUBLICATIONS | JOBS | SUPPORT US | NEWS | CONTACT 

©2016 Translational CLL Research at Dana-Farber Cancer Institute